Podcasts about sahpra

Johannesburg’s black market for medicine is growing as immigrants struggleto access clinics. But at what cost? Africa Melane speaks to SAHPRA’sManager for Regulatory Compliance, Mokgadi Fafudi about the dangers andsolutions.See omnystudio.com/listener for privacy information.

Lester Kiewit speaks to Tebogo Tlhopane, Chairperson of the Cannabis Trade Association Africa (CTAA) about the government’s u-turn on its ban on foodstuffs containing cannabis and hemp until they embark on further consultation.See omnystudio.com/listener for privacy information.

Clement Manyathela hosts Penny Campbell, the Director for the Food Control Unit at the National Department of Health; Dr Karl le Roux, the DA deputy spokesperson on health and Natie Ferreira, a cannabis farmer as they discuss the decision taken by the Department of Health to ban cannabis and hemp in food products.See omnystudio.com/listener for privacy information.

Resident GP & CEO of Proactive Health Solutions, Dr Fundile Nyati on what to make of the recall of a popular contraceptive "Yaz Plus" by SAHPRA and Bayer Pharmaceutical earlier this week.See omnystudio.com/listener for privacy information.

The South African Health Products Regulatory Authority has issued an urgent recall of a batch of YAZ Plus contraceptives due to a quality concern. The Health Products Regulatory Authority is advising the public to immediately stop consuming the tablet and return affected packs to their pharmacist. For more on this Elvis Presslin spoke to Dr. Boitumelo Semete-Makokotlela, Chief Executive Officer at SAHPRA

Resident GP & CEO of Proactive Health Solutions, Dr Fundile Nyati on concerns over compounded versions of hugely popular weight-loss and obesity drugs which have led to the deaths of at least 10 people and 100 hospitalisations overseas, prompting warnings from the drugmakers and the SA Health Products Regulatory Authority (SAHPRA). SAHPRA this week appealed to the public not to buy compounded versions of the drugs, saying there has been a concerning rise in falsified versions of these products being offered on websites and various social media platforms.See omnystudio.com/listener for privacy information.

Sahpra waarsku teen die gebruik van vervalste diabetesmiddels, wat vir gewigsverlies gebruik word. SADEK word gevra om 'n spesiale gesant na Mosambiek te stuur om die politieke krisis daar te besleg. Die Appèlhof beslis dat munisipale amptenare in hulle persoonlike hoedanigheid aanspreeklik gehou kan word vir die onreëlmatige en vrugtelose besteding van staatsgeld.

Crystal Ordeson is joined by Mokgadi Daphne Fafudi, Manager for Regulatory Compliance at SAHPRA, to discuss the dangers associated with these counterfeit medications and what consumers need to know to protect themselves. Ms. Fafudi will share insights on how SAHPRA is working to curb the sale of these products, the health risks involved, and how the public can help report suspicious products.See omnystudio.com/listener for privacy information.

Daphney Fafudi, Regulatory compliance manager at SAHPRA explains the draft guidelines to stem the use of the drug Codeine. See omnystudio.com/listener for privacy information.

SAHPRA clears Benylin Paediatric cough syrup after recall over toxic chemical fears by Radio Islam

The South African Health Products Regulatory Authority, SAHPRA says plans are in place to address codeine abuse. The plan is in response to high levels of the abuse of codeine-based medications like cough syrup particularly among the youth. For more on this Elvis Presslin spoke to SAHPRA's Inspectorate and Regulatory Compliance Manager, Mokgadi Fafudi

Die Suid-Afrikaanse Reguleringsowerheid vir Gesondheidsprodukte en die Medisyne-reguleringsowerheid van Botswana werk saam om medisyne te evalueer, goedkeuringsprosesse te vergemaklik, en nadelige reaksies na bemarking te monitor. Hulle het 'n verstandhoudingsooreenkoms onderteken om die regulering van plaaslike medisyne te verbeter. Hierdie vennootskap moet toegang tot nuwe medisyne verbeter, nagemaakte produkte beheer en regulatoriese inligting deel. Die woordvoerder van SAHPRA, Madimetja Mashishi, sê die ooreenkoms sluit gesamentlike optrede in om die onwettige invoer van ongeregistreerde medisyne te voorkom:

SAHPRA recalls batches of Benylin paediatric cough syrup | D Poovan by Radio Islam

SAHPRA has recalled 2 batches of Benilyn Paediatric Syrup. This after the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) shared a report on the detection of high levels of diethylene glycol in the medications. Lester Kiewit speaks to Deon Poovan, SAHPRA Senior manager: Inspectorate and Regulatory Compliance.See omnystudio.com/listener for privacy information.

Health products regulator, SAHPRA has recalled Lubria, a sterile lubricating jelly over contamination concerns. Website

Dr Johan Oosthuyse – CEO, V-Tech SAfm Market Update - Podcasts and live stream

The South African Health Products Regulatory Authority - SAHPRA -  has made the decision to withdraw pholcodine-containing medicines from the South African market due to the increased risk of sudden, severe, and life-threatening allergic reactions occurring during surgery. Pholcodine has been used as a cough suppressant since the 1950s. It is registered to treat dry coughs and is available in various non-prescription medicines. Sebenzile Nkambule spoke to Mafora Matlala, Pharmacovigilance Manager at Sahpra

Welcome to the 1st episode of the Dr Coffee Podcast for 2023!  We wish a happy and blessed New year to all of our listeners and followers. Whatever adventure 2023 has in store for you, I pray you have incredible success and above all enjoy it! In this week's episode, I interview a dynamic young brother and sister duo about health system innovation, studying medicine abroad, and the wait for internship placement when you return, amongst other things. My guests on the podcast today are Dr Brett Lyndall Singh and Dr Michaela Singh. Both are graduates out of Wenzhou Medical University in China, where they earned their bachelor of medicine and bachelor of surgery degrees. They're also the founders of Alpha and Omega MedTech, a Medical supplies platform and supplier of diagnostic and therapeutic medical devices. You'll hear them tell us more about their company and the journey behind it, but by way of introduction it's important to know that their company has one of the youngest founding teams to hold a license from SAHPRA. Dr Brett Singh has presented at a number of local and international business and health innovation summits, and his efforts have been recognised with his inclusion in the Forbes Africa Magazine's “30 under 30”, for which he was one of the cover models, as well as inclusion in the Mail and Guardian top 200 Young South Africans. Connect with Dr Brett Lyndall Singh on Instagram [@drbrettlyndall], Youtube, LinkedIn, & Twitter Connect with Dr Michaela Singh on Instagram [@michaelatsingh], & YouTube Thank you to our long-term partner of the Dr Coffee podcast - Aesthetikos Photography portrait studio. Check out their work and be sure to mention “Dr Coffee” when you make a booking with them to receive 15% off the price of your photography package. They're also on Instagram at @aesthetikos.studio If you have a suggestion of an episode topic, or know of a consultant or senior registrar in a specialty that YOU would like featured on the Dr Coffee Podcast, please get in touch. The podcast's email address is drcoffeeza@gmail.com. We're also on Instagram and Youtube, with the username “@DrCoffeeZA”. If you've got anything else on your mind, please get in touch, we'd love to hear from you. Please consider sharing this episode with fellow junior doctors and medical students in your world who you think would benefit from the content and enjoy it. It's as easy as two clicks - simply post/share the link to this episode, or tag @drcoffeeza in a post related to the content. Thank you so much for your support!

Taking a look at the five things you may have missed out on this Tuesday morning. Uber's latest safety feature rolled out in South Africa, medicine regulator SAHPRA has registered the HIV prevention jab, and much more. #DarrenKeriSkyOnECR #FiveThingsYouNeedToKnowAsYouWakeUp Former Cell C Sharks winger Sbu Nkosi has been found

Die Suid-Afrikaanse Reguleringsowerheid vir Gesondheidsprodukte het 'n toekenning vir sy entstof-regulering ontvang. Die Wêreldgesondheidsorganisasie het Sahpra op funksionele volwassenheid vlak-drie geplaas. Dit beteken hy het 'n bestendige, goed funksionerende en geïntegreerde regulatoriese stelsel om die gehalte, veiligheid en doeltreffendheid van die entstowwe wat hy registreer te verseker. Sahpra se woordvoerder, Yuven Gounden, sê vir 'n redelik nuwe onafhanklike reguleringsowerheid is dit inderdaad 'n noemenswaardige toekenning.

Scientist and CEO of Sahpra, Dr Boitumelo Semete-Makokotlela on her upbringing, the inspiration behind her hard work, some of the challenges she faced ever since her appointment as the CEO of South African Health Products Regulator and on her aspirations.   See omnystudio.com/listener for privacy information.

Die Suid-Afrikaanse Regulasie-owerheid vir Gesondheidsprodukte het die verlenging van vervaldatums van Covid-19-entstofdosisse goedgekeur. Die vervaldatum van miljoene dosisse is tot Desember en Januarie verleng. Meer as 8,5 miljoen Pfizer-dosisse sou aan die einde van volgende maand vernietig word. Volgens die uitvoerende hoof van Sahpra, Boitumelo Semete-Makokotlela, is die entstowwe steeds heeltemal veilig en doeltreffend:

Health products regulator, Sahpra has stressed that the benefits of the COVID-19 vaccines far outweigh the very low risk of severe adverse events.

CEO at SAHPRA Dr. Boitumelo Semete-Makokotlela discusses the public's concerns in light of the two deaths classified as vaccine-related, what is Guillain-Barre syndrome and how it is linked to vaccines, the critical symptoms to look for, and the past lessons learned in dealing with COVID-19 and vaccines. See omnystudio.com/listener for privacy information.

Inwoners van Kagiso in Krugersdorp spring in om Zama Zamas self aan die kaak te stel. Die gesondheidsprodukte-reguleerder, SAHPRA, sê een sterfte is na aanleiding van die Jonhson & Johnson-entstof teen Covid-19 aangemeld. Die Springbokke se geheime wapen teen die All Blacks op tuisgrond is soos altyd sy groot ondersteunerstal, maar wat van die talle Suid-Afrikaners wat nie die Bokke nie, maar die All Blacks steun?

Die Suid-Afrikaanse Gesondheidsprodukte-beheerraad het bevestig dat daar een sterfte aangemeld is nadat 'n Suid-Afrikaner 'n Johnson en Johnson Covid-inenting ontvang het. Sahpra sê dit is die eerste sterfte uit 160 sterftes ná 'n inenting waar die oorsaak regstreeks met inenting verbind kon word. Kosmos 94.1 Nuus se korrespondent in Kaapstad, Fritz Platt ...

South Africa's health regulator reported on Thursday a causal link between the death of an individual and Johnson & Johnson's (J&J) Covid-19 vaccine, the first time such a direct link has been made in the country. The person presented with rare neurological disorder Guillain-Barre Syndrome soon after being given J&J's vaccine, after which the person was put on a ventilator and later died, senior scientists told a news conference. "At the time of illness no other cause for the Guillain-Barre Syndrome (GBS) could be identified," Professor Hannelie Meyer said. The person's age and other personal details were not disclosed for confidentiality reasons. Last July, US authorities added a warning to a factsheet for J&J's vaccine saying data suggested there was an increased risk of GBS in the six weeks after vaccination. At the time it noted 100 preliminary reports of GBS in vaccine recipients, including 95 serious cases and one reported death. J&J did not immediately respond to an emailed request for comment. The company said at the time of the U.S. warning it was in discussions with regulators and the rate of reported cases of GBS in J&J vaccine recipients exceeded the background rate only slightly. "The benefit of vaccination still far outweighs the risk," Boitumelo Semete-Makokotlela, chief executive of the South African Health Products Regulatory Authority (SAHPRA), told reporters. "In our context we have administered about 9-million (doses) of the Janssen (J&J) vaccine, and this is the first causally linked case of GBS." Europe's medicines regulator last year added GBS as a possible side-effect of AstraZeneca's Covid vaccine which, like J&J's, uses viral vector technology. South Africa's Health Minister Joe Phaahla told Thursday's news conference that as of mid-July there had been just over 6 200 "adverse events" reported to SAHPRA out of the more than 37-million Covid vaccine doses administered in the country, equivalent to 0.017%. Semete-Makokotlela said the regulator had assessed around 160 deaths since the Covid vaccination rollout started but had not seen a causal link to vaccination until now. South Africa has been using shots from J&J and Pfizer in its Covid vaccination campaign. The rollout got off to a slow start due to difficulties securing supplies and protracted negotiations with pharmaceutical companies, but more recently it has been slowed by hesitancy. Around 46% of its adult population of 40-million is now fully vaccinated.

Guest: Ms. Mokgadi Fafudi SAHPRA Manager of Regulatory Compliance. On Monday, John spoke to Jamie Elkon, a clinical psychologist with a strong conviction that psychedelic medicine should be legalised for use in psychological and psychiatric therapy. Ms Mokgadi Fafudi joins us to explain the South African Health Product Authority's stance. See omnystudio.com/listener for privacy information.

  Thabo Mdluli is joined by the CEO of the South African Health Products Regulator (SAHPRA), Dr Boitumelo Semete-Makokotlela to talk about SAHPRA's decision to terminate the Ivermectin programme with immediate effect  See omnystudio.com/listener for privacy information.

South African Health Products Regulatory Authority (Sahpra) CEO Dr Boitumelo Semete announced on Monday the termination of the use of the Ivermectin drug for the treatment and prevention of Covid-19 in South Africa. The drug received significant worldwide public interest in 2020 as having some potential benefit in the management of Covid-19. The Sahpra said that there was currently no credible evidence to support a therapeutic role for Ivermectin in Covid-19. Unregistered Ivermectin products will not be allowed to be imported and health facilities will not be allowed to hold bulk stock in anticipation of prescriptions for such unregistered Ivermectin products. However, prescribers are still expected to report on the clinical outcomes of those patients for whom treatment approval was given prior. “Permission was granted to five importers of unregistered Ivermectin oral solid dosage forms, and health facilities were enabled to hold bulk stock, in anticipation of patient need. Individual named patient applications were still required, after prescribers had initiated use of Ivermectin. Sahpra also undertook to monitor the emerging evidence of safety and efficacy, for both treatment and prevention,” said Semete. She added that although there had been several developments in Ivermectin efficacy, Covid-19 vaccines are now widely available. The Sahpra has noted a decline in the number of health facilities applying for permission to hold bulk stock of Ivermectin since August 2021. Sahpra said it would continue to monitor the peer-reviewed, scientific literature regarding the safety and efficacy of Ivermectin.

The South African Health Products Regulatory Authority has come out in defense of all the approved vaccines in the country, declaring them safe to use, including the Pfizer vaccine. This follows widespread reaction to the news that the Pfizer vaccine has over one-thousand-two-hundred side effects that were not disclosed to the public, until only last week. SAHPRA held a webinar yesterday explaining COVID-19 vaccine safety, together with the difference between vaccine side effects and vaccine adverse events. Dr. Boitumelo Semete-Makoko-tlela, CEO of the South African Health Products Regulatory Authority elaborates

The SA Health Products Regulatory Authority (Sahpra)  said it is engaging with Pfizer about the report regarding vaccine side-effects that made the rounds last week. #VaccineSideEffects trended on social media last week after a “leaked” document detailing adverse health events experienced by people after receiving the Pfizer vaccine. The regulator reassured South Africans that the Covid-19 vaccines are safe.

Die moord op 'n 13-jarige seun ruk die gemeenskap van Klawer. 'n Gemeenskapsaktivis sê intussen sulke gruweldade gebeur gereeld op kleiner dorpe. SAHPRA keur die gebruik van twee nuwe Covid-19 entstowwe goed.

Die voormalige bedryfshoof van die SAUK, Hlaudi Motsoeneng, mis die spertyd om R11,5 miljoen aan die korporasie terug te betaal. Die ANC-Jeugliga eis stappe teen die direksie van Sedibeng Water. 'n Swart wingerdkundige van die Strand hehaal sy doktorsgraad. Sahpra het goedkeuring verleen vir die toediening van 'n skraagdosis van Johnson & Johnson se Covid-19-entstof. Meer as 100 mense sterf sedert die begin van die maand in motorongelukke op Wes-Kaapse paaie. ANC-personeel ontvang slegs 'n gedeelte van hulle agterstallige salarisse.

SAHPRA, the South African Health Products Regulatory Authority, has approved the Pfizer booster shot for Covid-19. But what do we know so far about the planned rollout? Refilwe Moloto speaks to Mia Malan, Director of the Bhekisisa Health Journalism Centre. See omnystudio.com/listener for privacy information.

News headlines: *A new study by the University of Cape Town (UCT) has found that while vaccine mandates might assist in improving uptake of the vaccines, only 40% of Africans supported them. *Scientists and researchers have welcomed SAHPRA's approval of a Pfizer Covid-19 vaccine booster shot, which will be available for anyone over the age of 18 six months after their second dose. *South African citizens are still getting the short end of the stick when it comes to value for tax money, with only 19% of the R1.9trn national and provincial government spending getting a clean audit in the 2020/21 financial year.

The country has recorded a major spike in new Covid-19 cases, that has pushed our positivity rate, up to 26.8%. 19 842 infections were registered in the last 24-hour cycle.

Guest: Silverani Padayachee | Senior Manager: Pharmaceutical Evaluation at South African Health Products Regulatory Authority (SAHPRA See omnystudio.com/listener for privacy information.

South Africa's health products regulator, Sahpra, has withheld approval for Russia's Sputnik V Covid vaccine over concerns that it could increase the risk of HIV infection among men.The decision was based on two earlier studies that tested the safety of a modified form of adenovirus contained in the Russian jab.The Gamaleya Institute, which developed Sputnik V, says it would produce information to show that Sahpra's concerns were completely unfounded.Sahpra says its concerns followed consultations with local and international experts.

South Africa's health products regulator, Sahpra, has withheld approval for Russia's Sputnik V Covid vaccine over concerns that it could increase the risk of HIV infection among men.The decision was based on two earlier studies that tested the safety of a modified form of adenovirus contained in the Russian jab.The Gamaleya Institute, which developed Sputnik V, says it would produce information to show that Sahpra's concerns were completely unfounded.Sahpra says its concerns followed consultations with local and international experts.

South Africa's health products regulator, Sahpra, has withheld approval for Russia's Sputnik V Covid vaccine over concerns that it could increase the risk of HIV infection among men.The decision was based on two earlier studies that tested the safety of a modified form of adenovirus contained in the Russian jab.The Gamaleya Institute, which developed Sputnik V, says it would produce information to show that Sahpra's concerns were completely unfounded.Sahpra says its concerns followed consultations with local and international experts.

Guest: Joan van Dyk | Senior journalist at Bhekisisa Health Journalism Centre  See omnystudio.com/listener for privacy information.

Health Products Regulator, SAHPRA has rejected an application for the use of Sputnik V vaccine in the country.

Guest: Dr. Boitumelo Semete-Makokotela South African Health Products Regulatory Authority, CEO   See omnystudio.com/listener for privacy information.

The South African Health Products Regulatory authority (SAHPRA) is evaluating the medical records of at least twenty-eight people who died after receiving their COVID-19 vaccine. Sahpra has received 3,730 reports of adverse effects following immunisation and 279 reports of what it terms adverse events of special interest. Speaking to Radio Islam, Chair of Sahpra, Professor Helen Rees says some of the adverse effects experienced by patients may not be related to the Coronavirus vaccine.

Some experts have maintained that reports of people who were presumably healthy who suddenly died after taking the jab are not backed by facts. Some South Africans have taken to social media to express their fears of taking the vaccine, citing such incidents, and stirring vaccine hesitancy. This as the Health Products Regulatory Authority, SAHPRA, reported that 28 people have died after the administration of both the Pfizer and Johnson and Johnson vaccines. The organization however says there is no evidence yet whether the patients died directly as a result of taking the vaccines and studies are currently underway in this regard. We now speak to the convenor of Progressive Health Forum, Dr. Aslam Dasoo See omnystudio.com/listener for privacy information.

Babalo Ndenze | Parliamentary Correspondent at EWN  See omnystudio.com/listener for privacy information.

Following the approval of the Sinovac vaccine by SAHPRA, 2.5 million vaccine doses have been made available to South Africa. Bongani speaks to Anton Arendse, Chief Operating Officer of Numolux Group. See omnystudio.com/listener for privacy information.

Solidariteit en AfriForum sal vandag hul stryd teen die Suid-Afrikaanse Gesondheidsprodukte regulerende owerheid SAHPRA, in die hof voer om SAHPRA se voorwaarde dat slegs die regering die Johnson & Johnson-entstof mag koop, tersyde te stel. Die twee organisasies bevraagteken die wettigheid van sulke voorwaardes en vra meer inligting rakende die voorwaardes soos gestel deur SAHPRA. AfriForum se hoof van regsake, Anton van der Bijl, verduidelik die aansoek aan Kosmos 94.1 Nuus.

Guest: Dr. Boitumelo Semete-Makokotela South African Health Products Regulatory Authority, CEO   See omnystudio.com/listener for privacy information.

Van der Bijl het ook die belangrikheid en gebruik van ivermektien verduidelik.

National spokesperson of the EFF, Vuyani Pambo, shares details of the planned EFF march to the SAHPRA offices this rmornng See omnystudio.com/listener for privacy information.

The South African Health Products Regulatory Authority (SAHPRA) says it has NOW received documentation for the Sinopharm vaccine developed by the China National Pharmaceutical Group in China and will now commence evaluating the data in order to assess the efficacy of the vaccine. The organisation says it is also in the process of reviewing the Russian Sputnik V vaccine. This as the Economic Freedom Fighters will TODAY march on SAHPRA offices in Pretoria, to demand that the Russian and Chinanese vaccines be approved for use in South Africa. See omnystudio.com/listener for privacy information.

Health experts have expressed support for the South African Health Regulatory Authority (SAHPRA), as the EFF plans to protest at its head office, demanding Covid-19 vaccines. Bongani speaks to Professor Shabir Madhi, Dean of the Faculty of Health Sciences at Wits University. See omnystudio.com/listener for privacy information.

Veronica Makhoali, EWN Reporter  See omnystudio.com/listener for privacy information.

Guest: Mia Malan | Director at Bhekisisa Health Journalism Centre See omnystudio.com/listener for privacy information.

Guest: Veronica Mente/ EFF National Chairperson  See omnystudio.com/listener for privacy information.

Guest: Dr. Boitumelo Semete-Makokotela South African Health Products Regulatory Authority, CEO   See omnystudio.com/listener for privacy information.

Silverani  Padayachee | Senior Manager: Pharmaceutical Evaluation at South African Health Products Regulatory Authority (SAHPRA ) See omnystudio.com/listener for privacy information.

Guest: Dr. Boitumelo Semete-Makokotela South African Health Products Regulatory Authority, CEO See omnystudio.com/listener for privacy information.

SAHPRA CEO Boitumelo Semete-Makokotlela briefed MP's on Wednesday that the SA Health Products Regulatory Authority is operating with only 290 out of 500 staff. Refilwe Moloto finds out why they fear this and a lack of budget may impact their speed and efficiency. See omnystudio.com/listener for privacy information.

Die gesondheisprodukte-beheeraad, Sahpra, sê die tydelike staking van inentings met die Johnson & Johnson-entstof moet opgehef word. 'n Voorstel dat laerskoolleerders weer voltyds skool moet bywoon, word deur die departement van basiese onderwys oorweeg. 'n Kaapse regisseur se rolprent, Love and Monsters, is vir 'n Oscar-toekenning benoem. Switserse en Walliese wetenskaplikes is besig om nuwe veevoer vir beeste te ontwikkel om metaangasuitlatings aansienlik te verminder.

Die Johnson & Johnson entstof is nog nie by SAHPRA geregistreer nie. 'n Groep begunstigdes van maatskaplike toelaes in Mosselbaai in die Suid-Kaap sukkel blykbaar al maande lank om hulle toelae te ontvang. Teaters kan weer hulle deure opmaak, maar is dit te min, te laat? Die eerste gedeeltelike knievervanging op 'n huiskat is onlangs uitgevoer.

South Africa’s joint lead investigator for the Johnson & Johnson COVID-19 vaccine trial on Tuesday said that a government regulator was processing an application for the vaccine to be granted emergency use authorisation.The official, Glenda Gray said discussions were underway with regulatory authorities to roll out the single-dose vaccine to health workers, after the government on Sunday halted distribution of the AstraZeneca vaccine over efficacy concerns.South Africa had given fast-track approval to AstraZeneca’s COVID-19 vaccine for emergency use last month and had said it was reviewing applications by Pfizer and Johnson & Johnson.Gray said J&J also submitted a rolling submission to SAHPRA to expedite the regulatory processes in South Africa, so this AD26 vaccine is being processed for emergency use.

Die gebruik van ivermektien om COVID-19 te behandel het behoorlik die land aan die gons. AfriForum het onlangs 'n skikking met SAHPRA bereik dat dokters wel ivermektien vir menslike gebruik mag voorskryf. Barend Uys kuier in die ateljee om meer hieroor te gesels.

Dokters is woedend oor SAHPRA se regulasies oor die menslike gebruik van Ivermektien, maar die reguleringsowerheid verdedig sy besluit. Ons hoor wat by die Zondo-kommissie gebeur. Die Boer-teater weier om die handoek in te gooi weens inperkingsregulasies. Die metaalwerkersunie, Numsa, en die Suid-Afrikaanse Vereniging vir Kajuitpersoneel, SACCA, se dringende aansoek in die Arbeidshof teen SAL se nie-betaling van werkers, is tot Maandag uitgestel. Die land se eerste Covid-19-entstof is op pad. Ons praat hieroor met die hoofredakteur van die Bkekisisa Sentrum vir Gesondheidjoernalistiek.

South African Health Products Regulatory Authority (SAHPRA) says it has now reviewed again, the available data from clinical studies. The authority says it encourages the submission of clinical trial applications designed to establish the safety and efficacy of ivermectin in the management of Covid-19 infections for both treatment and prophylaxis and commits to expediting their review….We spoke to Professor Helen Rees- Executive Director of the Wits Reproductive Health and HIV Institute and Chairman of the South African Health Products Regulatory Authority…

The South African Heath Products Regulatory Authority (SAHPRA) has issued a recall on blood pressure and heart condition drug, Dynaval Co, due to cancer fears. This follows findings that one of Dynaval Co's ingredients has been contaminated with chemicals that can possibly cause the disease. The contamination was found in Valsartan, which is imported from China. Similar recalls were recently made in Europe and the United States. akina Kmwendo spoke to SAHPRA's representative, Florah Matlala